Journal of the American Chemical Society · 2008 · 75 citations · 59 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryAmino Acid-derived Natural ProductsEnzyme InhibitionMacrocycle SynthesisNatural Product Drug DiscoveryPeptide ChemistryPeptide Drug DiscoveryCyclopeptide SynthesisNatural Product Total SynthesisPositionS- ConfigurationTotal Synthesis-derived AnaloguesTubulin Polymerization Inhibitors
Ustiloxins A-F are antimitotic heterodetic cyclopeptides containing a 13-membered cyclic core structure with a synthetically challenging chiral tertiary alkyl-aryl ether linkage. The first total synthesis of ustiloxin D was achieved in 31 linear steps using an S(N)Ar reaction. An NOE study of this synthetic product showed that ustiloxin D existed as a single atropisomer. Subsequently, highly concise and convergent syntheses of ustiloxins D and F were developed by utilizing a newly discovered ethynyl aziridine ring-opening reaction in a longest linear sequence of 15 steps. The approach was further optimized to achieve a better macrolactamization strategy. Ustiloxins D, F, and eight analogues (14-MeO-ustiloxin D, four analogues with different amino acid residues at the C-6 position, and three (9R,10S)-epi-ustiloxin analogues) were prepared via the second-generation route. Evaluation of these compounds as inhibitors of tubulin polymerization demonstrated that variation at the C-6 position is tolerated to a certain extent. In contrast, the S configuration of the C-9 methylamino group and a free phenolic hydroxyl group are essential for inhibition of tubulin polymerization.
59
Asymmetric Allylic Alkylation, an Enabling Methodology
Barry M. Trost · The Journal of Organic Chemistry · 2004 · 528 citations
Grace Mann, John F. Hartwig · Journal of the American Chemical Society · 1996 · 316 citations